The effects of pharmacologic doses of 2-deoxy-d-glucose on local cerebral blood flow in the awake, unrestrained rat

Alan Breier, Alison M. Crane, Charles Kennedy, Louis Sokoloff

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Previous study of the effects of acute insulin-induced hypoglycemia on cerebral blood flow (CBF) have resulted in conflicting results. An alternate approach to the study of glucoprivation is the administration of pharmacologic doses of the glucose analogue, 2-deoxy-d-glucose (2-DG). 2-DG is transported across the blood-brain barrier tissue where it is phosphorylated to 2-deoxy-d-6-phospahte (2-DG-6-P) but not metabolized further. The 2-DG-6-P accumulates and inhibits the conversion of glucose-6-phosphate to fructose-6-phosphate, thus blocking glycolysis and glucose metabolism. In the present study we have employed the [14C]iodoantipyrine method to examine the effects of a pharmacologic dose (5 mg/kg) of 2-DG on local cerebral blood flow (ICBF) regions of the brain in conscious, unrestrained, adult male rats. The 2-DG treatment raised arterial plasma glucose levels from 8 to 17 mM without affecting arterial blood pO2, pCO2 or pH but increased lCBF in most brain regions examined. The largest increases were in the cerebral cortex, basal ganglia, and thalamic nuclei (+65 to +157%). Smaller increases were found in most structures of the limbic system, brainstem, and white matter, and no changes in lCBF were seen in the cerebellar cortex and ventral medial hypothalamus. The results indicate that cerebral glucoprivation produced by pharmacological doses of 2-deoxyglucose is accompanied by substantial increase in blood flow in most regions of the brain.

Original languageEnglish (US)
Pages (from-to)277-282
Number of pages6
JournalBrain Research
Volume618
Issue number2
DOIs
StatePublished - Aug 6 1993
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Glucose
Basal Ganglia
Brain
Middle Hypothalamus
Thalamic Nuclei
Limbic System
Glucose-6-Phosphate
Cerebellar Cortex
Deoxyglucose
Glycolysis
Blood-Brain Barrier
Hypoglycemia
Cerebral Cortex
Brain Stem

Keywords

  • Deoxyglucose
  • Glucose deprivation
  • Glycolytic blocked

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

The effects of pharmacologic doses of 2-deoxy-d-glucose on local cerebral blood flow in the awake, unrestrained rat. / Breier, Alan; Crane, Alison M.; Kennedy, Charles; Sokoloff, Louis.

In: Brain Research, Vol. 618, No. 2, 06.08.1993, p. 277-282.

Research output: Contribution to journalArticle

Breier, Alan ; Crane, Alison M. ; Kennedy, Charles ; Sokoloff, Louis. / The effects of pharmacologic doses of 2-deoxy-d-glucose on local cerebral blood flow in the awake, unrestrained rat. In: Brain Research. 1993 ; Vol. 618, No. 2. pp. 277-282.
@article{4ca4fcf92d3a4a2f85ecf8bfddfcf6c5,
title = "The effects of pharmacologic doses of 2-deoxy-d-glucose on local cerebral blood flow in the awake, unrestrained rat",
abstract = "Previous study of the effects of acute insulin-induced hypoglycemia on cerebral blood flow (CBF) have resulted in conflicting results. An alternate approach to the study of glucoprivation is the administration of pharmacologic doses of the glucose analogue, 2-deoxy-d-glucose (2-DG). 2-DG is transported across the blood-brain barrier tissue where it is phosphorylated to 2-deoxy-d-6-phospahte (2-DG-6-P) but not metabolized further. The 2-DG-6-P accumulates and inhibits the conversion of glucose-6-phosphate to fructose-6-phosphate, thus blocking glycolysis and glucose metabolism. In the present study we have employed the [14C]iodoantipyrine method to examine the effects of a pharmacologic dose (5 mg/kg) of 2-DG on local cerebral blood flow (ICBF) regions of the brain in conscious, unrestrained, adult male rats. The 2-DG treatment raised arterial plasma glucose levels from 8 to 17 mM without affecting arterial blood pO2, pCO2 or pH but increased lCBF in most brain regions examined. The largest increases were in the cerebral cortex, basal ganglia, and thalamic nuclei (+65 to +157{\%}). Smaller increases were found in most structures of the limbic system, brainstem, and white matter, and no changes in lCBF were seen in the cerebellar cortex and ventral medial hypothalamus. The results indicate that cerebral glucoprivation produced by pharmacological doses of 2-deoxyglucose is accompanied by substantial increase in blood flow in most regions of the brain.",
keywords = "Deoxyglucose, Glucose deprivation, Glycolytic blocked",
author = "Alan Breier and Crane, {Alison M.} and Charles Kennedy and Louis Sokoloff",
year = "1993",
month = "8",
day = "6",
doi = "10.1016/0006-8993(93)91276-X",
language = "English (US)",
volume = "618",
pages = "277--282",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The effects of pharmacologic doses of 2-deoxy-d-glucose on local cerebral blood flow in the awake, unrestrained rat

AU - Breier, Alan

AU - Crane, Alison M.

AU - Kennedy, Charles

AU - Sokoloff, Louis

PY - 1993/8/6

Y1 - 1993/8/6

N2 - Previous study of the effects of acute insulin-induced hypoglycemia on cerebral blood flow (CBF) have resulted in conflicting results. An alternate approach to the study of glucoprivation is the administration of pharmacologic doses of the glucose analogue, 2-deoxy-d-glucose (2-DG). 2-DG is transported across the blood-brain barrier tissue where it is phosphorylated to 2-deoxy-d-6-phospahte (2-DG-6-P) but not metabolized further. The 2-DG-6-P accumulates and inhibits the conversion of glucose-6-phosphate to fructose-6-phosphate, thus blocking glycolysis and glucose metabolism. In the present study we have employed the [14C]iodoantipyrine method to examine the effects of a pharmacologic dose (5 mg/kg) of 2-DG on local cerebral blood flow (ICBF) regions of the brain in conscious, unrestrained, adult male rats. The 2-DG treatment raised arterial plasma glucose levels from 8 to 17 mM without affecting arterial blood pO2, pCO2 or pH but increased lCBF in most brain regions examined. The largest increases were in the cerebral cortex, basal ganglia, and thalamic nuclei (+65 to +157%). Smaller increases were found in most structures of the limbic system, brainstem, and white matter, and no changes in lCBF were seen in the cerebellar cortex and ventral medial hypothalamus. The results indicate that cerebral glucoprivation produced by pharmacological doses of 2-deoxyglucose is accompanied by substantial increase in blood flow in most regions of the brain.

AB - Previous study of the effects of acute insulin-induced hypoglycemia on cerebral blood flow (CBF) have resulted in conflicting results. An alternate approach to the study of glucoprivation is the administration of pharmacologic doses of the glucose analogue, 2-deoxy-d-glucose (2-DG). 2-DG is transported across the blood-brain barrier tissue where it is phosphorylated to 2-deoxy-d-6-phospahte (2-DG-6-P) but not metabolized further. The 2-DG-6-P accumulates and inhibits the conversion of glucose-6-phosphate to fructose-6-phosphate, thus blocking glycolysis and glucose metabolism. In the present study we have employed the [14C]iodoantipyrine method to examine the effects of a pharmacologic dose (5 mg/kg) of 2-DG on local cerebral blood flow (ICBF) regions of the brain in conscious, unrestrained, adult male rats. The 2-DG treatment raised arterial plasma glucose levels from 8 to 17 mM without affecting arterial blood pO2, pCO2 or pH but increased lCBF in most brain regions examined. The largest increases were in the cerebral cortex, basal ganglia, and thalamic nuclei (+65 to +157%). Smaller increases were found in most structures of the limbic system, brainstem, and white matter, and no changes in lCBF were seen in the cerebellar cortex and ventral medial hypothalamus. The results indicate that cerebral glucoprivation produced by pharmacological doses of 2-deoxyglucose is accompanied by substantial increase in blood flow in most regions of the brain.

KW - Deoxyglucose

KW - Glucose deprivation

KW - Glycolytic blocked

UR - http://www.scopus.com/inward/record.url?scp=0027292392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027292392&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(93)91276-X

DO - 10.1016/0006-8993(93)91276-X

M3 - Article

C2 - 8374758

AN - SCOPUS:0027292392

VL - 618

SP - 277

EP - 282

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -